Ireland’s National Immunisation Advisory Committee (NIAC) has recommended that use of the Oxford-AstraZeneca vaccine is temporarily suspended after Norwegian regulators reported “serious blood clotting events”.
Unveiling the World's News
Ireland’s National Immunisation Advisory Committee (NIAC) has recommended that use of the Oxford-AstraZeneca vaccine is temporarily suspended after Norwegian regulators reported “serious blood clotting events”.